The analyst rating from JPMorgan's research report is influenced by several factors:
1. Positive GGR Performance: Macau's Gross Gaming Revenue (GGR) for February rose by 4% year-over-year, reaching MOP20.6 billion, which exceeded both market and broker expectations. This indicates a strong recovery and demand in the gaming sector.
2. High-End Customer Demand: There was a notable increase in average daily GGR, particularly in the last week of February, driven by strong demand from high-end customers. This suggests a robust market for premium offerings.
3. Selectivity in Investment: Despite the positive signs, JPMorgan advised investors to maintain selectivity within the industry. This indicates a cautious approach, suggesting that not all stocks are equally favorable.
4. Preference for Specific Stocks: The broker expressed a preference for GALAXY ENT over SANDS CHINA and MGM CHINA, indicating a strategic choice based on performance expectations and target prices.
5. Differentiation in Ratings: While some stocks were rated as Overweight, others like SJM HOLDINGS and MELCO INTERNATIONAL DEVELOPMENT were rated as Underweight, reflecting a more nuanced view of the sector's potential.
Overall, the analyst rating reflects a combination of strong recent performance, selective investment strategy, and differentiated outlooks for various companies within the gaming industry.
UBS
UBS
maintain
$46.9
2026-02-27
New
Reason
UBS
UBS
Price Target
$46.9
2026-02-27
New
maintain
Reason
The analyst rating for GALAXY ENT is "Buy" based on several positive financial indicators. The company's 4Q25 adjusted EBITDA was approximately $4.3 billion, reflecting a significant year-over-year increase of about 33% and a quarter-over-quarter increase of about 29%. Even when adjusted for VIP hold, the EBITDA of approximately $3.6 billion still showed a healthy growth of 9% YoY and 7% QoQ, aligning with estimates. Additionally, GALAXY ENT announced a final dividend per share (DPS) of $0.8, which exceeded market expectations of $0.65, resulting in a full-year DPS of $1.5 and a higher dividend payout ratio of about 61% compared to 50% in 2024. These strong financial results and positive outlook contributed to the broker's decision to set a target price of $46.9 for the stock.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for 00027
